Diaphragm movement sensor for phrenic nerve monitoring during cryoballoon procedures: the first clinical evaluation

Background and aimsRight phrenic nerve palsy is the most frequent complication of cryoballoon procedures. The SMARTFREEZE™ console (Boston Scientific, St. Paul, MN, USA) has integrated a new tool for diaphragm monitoring—the Diaphragm Movement Sensor; however, it has not been evaluated in clinical p...

Full description

Bibliographic Details
Main Authors: Elsa Schemoul, Lilith Tovmassian, Julien Mancini, Linda Koutbi, Cédric Biermé, Jean-Claude Deharo, Frédéric Franceschi, Baptiste Maille
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-03-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2024.1361761/full
_version_ 1797256479344951296
author Elsa Schemoul
Lilith Tovmassian
Julien Mancini
Julien Mancini
Linda Koutbi
Cédric Biermé
Jean-Claude Deharo
Jean-Claude Deharo
Frédéric Franceschi
Frédéric Franceschi
Baptiste Maille
Baptiste Maille
author_facet Elsa Schemoul
Lilith Tovmassian
Julien Mancini
Julien Mancini
Linda Koutbi
Cédric Biermé
Jean-Claude Deharo
Jean-Claude Deharo
Frédéric Franceschi
Frédéric Franceschi
Baptiste Maille
Baptiste Maille
author_sort Elsa Schemoul
collection DOAJ
description Background and aimsRight phrenic nerve palsy is the most frequent complication of cryoballoon procedures. The SMARTFREEZE™ console (Boston Scientific, St. Paul, MN, USA) has integrated a new tool for diaphragm monitoring—the Diaphragm Movement Sensor; however, it has not been evaluated in clinical practice. We aimed to assess the diagnostic performance of the Diaphragm Movement Sensor based on compound motor action potential data recorded simultaneously.MethodsThirty consecutive patients (mean age 63.2 ± 10.2 years) were included. We simultaneously recorded the compound motor action potential and the Diaphragm Movement Sensor during cryoapplications in the right pulmonary veins. The right phrenic nerve was paced at 60 per minute, 12 V and 2.9 ms. Compound motor action potential monitoring with a 30% decrease cutoff for the diagnosis of phrenic nerve threatening was considered the gold standard. The Diaphragm Movement Sensor decrease threshold was also set at 30%.ResultsConsidering compound motor action potential monitoring, phrenic nerve threatening occurred 11 times (in seven patients) among 84 cryoapplications (13.1%) at the right pulmonary veins. The sensitivity and specificity of the Diaphragm Movement Sensor were, respectively, 33% (95% CI: 7%–70%) and 49% (95% CI: 38%–61%; P < 0.001). The predictive positive and negative values for the Diaphragm Movement Sensor were, respectively, 7% (95% CI: 2%–20%) and 86% (95% CI: 72%–95%). The Diaphragm Movement Sensor gave an erroneous diagnosis in 44/84 cryoapplications (52.4%).ConclusionsThe diagnostic performance of the Diaphragm Movement Sensor is low, and the relevance of its use in clinical practice may be debated.
first_indexed 2024-04-24T22:22:24Z
format Article
id doaj.art-592aeb9658074e1b855acbd813878441
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-04-24T22:22:24Z
publishDate 2024-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-592aeb9658074e1b855acbd8138784412024-03-20T05:13:29ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2024-03-011110.3389/fcvm.2024.13617611361761Diaphragm movement sensor for phrenic nerve monitoring during cryoballoon procedures: the first clinical evaluationElsa Schemoul0Lilith Tovmassian1Julien Mancini2Julien Mancini3Linda Koutbi4Cédric Biermé5Jean-Claude Deharo6Jean-Claude Deharo7Frédéric Franceschi8Frédéric Franceschi9Baptiste Maille10Baptiste Maille11Department of Cardiology, CHU Timone, Aix-Marseille University, Marseille, FranceDepartment of Cardiology, CHU Timone, Aix-Marseille University, Marseille, FranceDepartment of Cardiology, CHU Timone, Aix-Marseille University, Marseille, FranceBiostatistics Department, Aix-Marseille University, INSERM, IRD, ISSPAM, APHM, SESSTIM, Hôpital de la Timone, Marseille, FranceDepartment of Cardiology, CHU Timone, Aix-Marseille University, Marseille, FranceDepartment of Cardiology, CHU Timone, Aix-Marseille University, Marseille, FranceDepartment of Cardiology, CHU Timone, Aix-Marseille University, Marseille, FranceCenter for CardioVascular and Nutrition Research (C2VN), INSERM, INRA, Marseille, FranceDepartment of Cardiology, CHU Timone, Aix-Marseille University, Marseille, FranceCenter for CardioVascular and Nutrition Research (C2VN), INSERM, INRA, Marseille, FranceDepartment of Cardiology, CHU Timone, Aix-Marseille University, Marseille, FranceCenter for CardioVascular and Nutrition Research (C2VN), INSERM, INRA, Marseille, FranceBackground and aimsRight phrenic nerve palsy is the most frequent complication of cryoballoon procedures. The SMARTFREEZE™ console (Boston Scientific, St. Paul, MN, USA) has integrated a new tool for diaphragm monitoring—the Diaphragm Movement Sensor; however, it has not been evaluated in clinical practice. We aimed to assess the diagnostic performance of the Diaphragm Movement Sensor based on compound motor action potential data recorded simultaneously.MethodsThirty consecutive patients (mean age 63.2 ± 10.2 years) were included. We simultaneously recorded the compound motor action potential and the Diaphragm Movement Sensor during cryoapplications in the right pulmonary veins. The right phrenic nerve was paced at 60 per minute, 12 V and 2.9 ms. Compound motor action potential monitoring with a 30% decrease cutoff for the diagnosis of phrenic nerve threatening was considered the gold standard. The Diaphragm Movement Sensor decrease threshold was also set at 30%.ResultsConsidering compound motor action potential monitoring, phrenic nerve threatening occurred 11 times (in seven patients) among 84 cryoapplications (13.1%) at the right pulmonary veins. The sensitivity and specificity of the Diaphragm Movement Sensor were, respectively, 33% (95% CI: 7%–70%) and 49% (95% CI: 38%–61%; P < 0.001). The predictive positive and negative values for the Diaphragm Movement Sensor were, respectively, 7% (95% CI: 2%–20%) and 86% (95% CI: 72%–95%). The Diaphragm Movement Sensor gave an erroneous diagnosis in 44/84 cryoapplications (52.4%).ConclusionsThe diagnostic performance of the Diaphragm Movement Sensor is low, and the relevance of its use in clinical practice may be debated.https://www.frontiersin.org/articles/10.3389/fcvm.2024.1361761/fullatrial fbrillationcryoballoon ablationcomplicationphrenic nerve—injuriesCMAP
spellingShingle Elsa Schemoul
Lilith Tovmassian
Julien Mancini
Julien Mancini
Linda Koutbi
Cédric Biermé
Jean-Claude Deharo
Jean-Claude Deharo
Frédéric Franceschi
Frédéric Franceschi
Baptiste Maille
Baptiste Maille
Diaphragm movement sensor for phrenic nerve monitoring during cryoballoon procedures: the first clinical evaluation
Frontiers in Cardiovascular Medicine
atrial fbrillation
cryoballoon ablation
complication
phrenic nerve—injuries
CMAP
title Diaphragm movement sensor for phrenic nerve monitoring during cryoballoon procedures: the first clinical evaluation
title_full Diaphragm movement sensor for phrenic nerve monitoring during cryoballoon procedures: the first clinical evaluation
title_fullStr Diaphragm movement sensor for phrenic nerve monitoring during cryoballoon procedures: the first clinical evaluation
title_full_unstemmed Diaphragm movement sensor for phrenic nerve monitoring during cryoballoon procedures: the first clinical evaluation
title_short Diaphragm movement sensor for phrenic nerve monitoring during cryoballoon procedures: the first clinical evaluation
title_sort diaphragm movement sensor for phrenic nerve monitoring during cryoballoon procedures the first clinical evaluation
topic atrial fbrillation
cryoballoon ablation
complication
phrenic nerve—injuries
CMAP
url https://www.frontiersin.org/articles/10.3389/fcvm.2024.1361761/full
work_keys_str_mv AT elsaschemoul diaphragmmovementsensorforphrenicnervemonitoringduringcryoballoonproceduresthefirstclinicalevaluation
AT lilithtovmassian diaphragmmovementsensorforphrenicnervemonitoringduringcryoballoonproceduresthefirstclinicalevaluation
AT julienmancini diaphragmmovementsensorforphrenicnervemonitoringduringcryoballoonproceduresthefirstclinicalevaluation
AT julienmancini diaphragmmovementsensorforphrenicnervemonitoringduringcryoballoonproceduresthefirstclinicalevaluation
AT lindakoutbi diaphragmmovementsensorforphrenicnervemonitoringduringcryoballoonproceduresthefirstclinicalevaluation
AT cedricbierme diaphragmmovementsensorforphrenicnervemonitoringduringcryoballoonproceduresthefirstclinicalevaluation
AT jeanclaudedeharo diaphragmmovementsensorforphrenicnervemonitoringduringcryoballoonproceduresthefirstclinicalevaluation
AT jeanclaudedeharo diaphragmmovementsensorforphrenicnervemonitoringduringcryoballoonproceduresthefirstclinicalevaluation
AT fredericfranceschi diaphragmmovementsensorforphrenicnervemonitoringduringcryoballoonproceduresthefirstclinicalevaluation
AT fredericfranceschi diaphragmmovementsensorforphrenicnervemonitoringduringcryoballoonproceduresthefirstclinicalevaluation
AT baptistemaille diaphragmmovementsensorforphrenicnervemonitoringduringcryoballoonproceduresthefirstclinicalevaluation
AT baptistemaille diaphragmmovementsensorforphrenicnervemonitoringduringcryoballoonproceduresthefirstclinicalevaluation